Cyclosporins to treat Alzheimer's disease

Details for Australian Patent Application No. 2005261838 (hide)

Owner Novartis AG

Inventors Cohen, Dalia; Gaither, Larry Alexander

Agent Davies Collison Cave

Pub. Number AU-A-2005261838

PCT Pub. Number WO2006/005580

Priority 60/587,770 13.07.04 US

Filing date 12 July 2005

Wipo publication date 19 January 2006

International Classifications

A61K 38/13 (2006.01) Medicinal preparations containing peptides

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07K 7/64 (2006.01) Peptides having 5 to 20 amino acids in a fully defined sequence

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/005580 Priority application(s): WO2006/005580

10 September 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261844

2005261837-Motion rate sensor